Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2010
10/14/2010US20100261612 Purification and Concentration of Proteins and DNA from a Complex Sample Using Isotachophoresis and a Device to Perform the Purification
10/14/2010US20100261291 Nucleic acids specifically binding bioactive ghrelin
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100261226 Universal bioreactors and methods of use
10/14/2010US20100261225 Apparatus and method for analyzing bacteria
10/14/2010US20100261223 Device for detecting components in a fluid
10/14/2010US20100261222 Cell culture measuring system and method for comparative investigations on cell cultures
10/14/2010US20100261221 Method to predict or diagnose a gastrointestinal disorder or disease
10/14/2010US20100261220 Biological system and assay for identifying modulators of tubulin ligases
10/14/2010US20100261219 Test method of bioavailability and bioequivalence for xenobiotics using genetic profiling
10/14/2010US20100261218 Methods for producing secondary metabolites
10/14/2010US20100261217 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/14/2010US20100261216 Stability testing of antibodies
10/14/2010US20100261215 Non-invasive method for collecting biological data for establishing a diagnosis of a cutaneous pathology
10/14/2010US20100261214 Method for Determining ACE2 Activity
10/14/2010US20100261213 Method for large scale preparation of the active domain of human protein tyrosine phosphatase without fusion protein
10/14/2010US20100261212 Kinetics of molecular recognition mediated nanoparticle self-assembly
10/14/2010US20100261211 Method and apparatus for monitoring spatial fibrin clot formation
10/14/2010US20100261210 Compositions and methods for diagnosing and treating prostate cancer
10/14/2010US20100261193 Valve Structure for Consistent Valve Operation of a Miniaturized Fluid Delivery and Analysis System
10/14/2010US20100261192 Cloning of cytochrome p450 genes from nicotiana
10/14/2010US20100261191 Stable cell lines expressing herg
10/14/2010US20100261190 Mammalian Genes; Related Reagents and Methods
10/14/2010US20100261189 System and method for detection of HLA Variants
10/14/2010US20100261188 Non-invasive prenatal genetic screen
10/14/2010US20100261187 kit for detecting specific single nucleotide polymorphisms (SNPs) in the human genome, and their association with acute coronary events and/or variability in the responsiveness to statin treatment (including preventive treatment) between different individuals; assessing for risk of heart disease
10/14/2010US20100261186 Polymorphism identification method
10/14/2010US20100261185 Labeled enzyme compositions, methods and systems
10/14/2010US20100261184 Micro-Chamber Plate, Manufacturing Method Thereof
10/14/2010US20100261183 Method of determining risk for cancer
10/14/2010US20100261182 Ppm1e proteins and nucleic acids as targets for neurodegenerative diseases
10/14/2010US20100261181 Labeling and detection of nucleic acids
10/14/2010US20100261180 Recombinant perforin, expression and uses thereof
10/14/2010US20100261179 Sample preparation devices and analyzers
10/14/2010US20100261178 High Throughput Assays for Inhibitors and Activators of PAQR Receptors
10/14/2010US20100261177 INCREASING SPECIFICITY IN A scFV SCREEN USING DUAL BAIT REPORTERS
10/14/2010US20100261176 Methods of Tissue-Based Diagnosis
10/14/2010US20100261175 Use of short oligonucleotides for reagent redundancy experiments in rna functional analysis
10/14/2010US20100261174 Determination of 5-ASA efficacy in CRC prevention and/or treatment by gene expression analysis
10/14/2010US20100261173 Identification Of Fat And Lean Phenotypes In Chickens Using Molecular Markers
10/14/2010US20100261172 Interferon alpha-induced pharmacodynamic markers
10/14/2010US20100261171 Nucleic acid sequences for biosynthesis of non-mccj25-related lariat peptides
10/14/2010US20100261170 Screening methods and sequences relating thereto
10/14/2010US20100261169 Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
10/14/2010US20100261168 Screening for Environmental DNAs Encoding Enzymes for Synthesizing Terpenoid-Based Therapeutic Compounds Using Genetically Modified E. Coli Strains
10/14/2010US20100261167 In vivo screen using chemical inducers of dimerization
10/14/2010US20100261166 Method for specifically and sensitively amplifying a target sequence
10/14/2010US20100261165 Methods, Compositions and Kits for Use in Prognosis, Characterization and Treatment of Cancer
10/14/2010US20100261164 Diagnostic detection of nucleic acids
10/14/2010US20100261163 Method for simultaneous detection of Mycobacterium tuberculosis complex and identification of mutations in mycobacterial DNA resulting in the resistance of microorganisms to rifampicin and isoniazid on biological microarrays, set of primers, biochip, and set of oligonucleotide probes used in the method
10/14/2010US20100261162 Methods of assaying for telomerase activity and compositions related to same
10/14/2010US20100261161 Method for determining the specific growth rate of a distinct cell population within a non-homogeneous system
10/14/2010US20100261160 Methods of screening for modulators of cell proliferation and methods of diagnosing cell proliferation states
10/14/2010US20100261159 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
10/14/2010US20100261158 Method and System for Multiplex Genetic Analysis
10/14/2010US20100261157 Device and Method for Processing a Sample Contained in a Swab for Diagnostic Analysis
10/14/2010US20100261156 Reagent for detecting hiv-1 antigen and detection method
10/14/2010US20100261155 Methods and compositions relating to viral fusion proteins
10/14/2010US20100261154 Primers and probes for detecting hepatitis c virus
10/14/2010US20100261153 Methods For Direct Fluorescent Antibody Virus Detection In Liquids
10/14/2010US20100261072 Enzyme electrode
10/14/2010US20100260861 Treatments with helminths
10/14/2010US20100260828 Modulation of Platelet Aggregation
10/14/2010US20100260827 Methods of diagnosing, preventing and treating cancer metastasis
10/14/2010US20100260805 Peptide for vaccine
10/14/2010US20100260804 Attenuated Uracil Auxotroph of an Apicomplexan and Use Thereof
10/14/2010US20100260789 Products specific to pathogenic strains and their use as vaccines and in immunotherapy
10/14/2010US20100260774 Netrin-1 Compositions and Methods of Use Thereof
10/14/2010US20100260771 Method for Diagnosing the Metabolic Syndrome (MS)
10/14/2010US20100260746 Novel Bank1 Splice Variant
10/14/2010US20100260740 Methods for preventing and/or treating lysosomal storage disorders
10/14/2010US20100260738 Uses and methods relating to ndr kinase expression and/or activity
10/14/2010US20100260736 Egr1 modulators for the treatment of alopecia
10/14/2010US20100260731 Propagation of primary cells and the use thereof
10/14/2010US20100260729 Corn Event PV-ZMIR13 (MON863) Plants and Compositions and Methods for Detection Thereof
10/14/2010US20100260724 Method for measuring the plasmine activity of microparticles present in a sample of a biological fluid and use thereof
10/14/2010US20100260680 Novel bone mass increasing agent
10/14/2010US20100260675 Oxytocin Receptor Antagonists and Their Use for the Treatment of Pulmonary Related Diseases
10/14/2010US20100260673 Phage display peptide probes for imaging early responses to antiangiogenic treatment
10/14/2010US20100260670 ALTERNATIVE SPLICE VARIANT PATTERNS OF HUMAN TELOMERASE REVERSE TRANSCRIPTASE (hTERT) IN THYROID TUMORS TO DISTINGUISH BENIGN FROM MALIGNANT
10/14/2010US20100260667 Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease
10/14/2010US20100258438 Biosensor
10/14/2010DE102009024673A1 Modifikation von Schichtsilikaten für die Lumineszenzaktivierung Modification of layered silicates for Lumineszenzaktivierung
10/14/2010CA2758310A1 Rice zinc finger protein transcription factor dst and use thereof for regulating drought and salt tolerance
10/14/2010CA2758271A1 Methods for preventing and/or treating lysosomal storage disorders
10/14/2010CA2758179A1 Genetic marker identification in atlantic cod
10/14/2010CA2758083A1 Single-use microfluidic test cartridge for the bioassay of analytes
10/14/2010CA2757941A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
10/14/2010CA2757927A1 Methods of predicting cancer risk using gene expression in premalignant tissue
10/14/2010CA2757884A1 Dna-cell conjugates
10/14/2010CA2757723A1 Method of predicting a predisposition to qt prolongation based on abcc2 gene sequence or product thereof
10/14/2010CA2757717A1 Method of predicting a predisposition to qt prolongation
10/14/2010CA2757713A1 Method of treatment based on polymorphisms of the kcnq1 gene
10/14/2010CA2757659A1 Biomarkers for monitoring treatment of neuropsychiatric diseases
10/14/2010CA2757646A1 Method of predicting a predisposition to qt prolongation based on bai3 gene sequence or product thereof
10/14/2010CA2756833A1 Targeted integration into stem cells
10/14/2010CA2756824A1 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
10/14/2010CA2754412A1 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjogren's syndrome
10/13/2010EP2239581A1 Phosphorylation of histone H3 at threonine 11 - a novel epigenetic mark for transcriptional regulation
10/13/2010EP2239580A1 Determination of 5-ASA efficacy in CRC prevention and/or treatment by gene expression analysis
1 ... 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 ... 3003